[size=7.4835pt]OBJECTIVE [size=8.4813pt]To consider the revised AA criteria and to offer an alternative definitional view of
[size=8.4813pt]AD as a clinical-biological construct for clinical use. The recommendations of the 2021 IWG
[size=8.4813pt]diagnostic criteria are updated for further elaborating at-risk and presymptomatic states.